Colorectal cancer 1

Common Name(s)

Colorectal cancer 1

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Colorectal cancer 1" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Colorectal cancer 1" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Colorectal cancer 1" returned 285 free, full-text research articles on human participants. First 3 results:

Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
 

Author(s): Hong Liu, Guoping Ren, Tingyang Wang, Yuexia Chen, Chaoju Gong, Yanfeng Bai, Bo Wang, Hongyan Qi, Jing Shen, Lijun Zhu, Cheng Qian, Maode Lai, Jimin Shao

Journal: Carcinogenesis. 2015 Apr;36(4):459-68.

 

The pro-inflammatory cytokine interleukin-6 (IL-6) in tumor microenvironment has been suggested to promote development and progression of colorectal cancer (CRC). However, the underlying molecular mechanisms remain elusive. In this study, we demonstrate that fos-related antigen-1 ...

Last Updated: 11 Apr 2015

Go To URL
Implication of metastasis suppressor gene, Kiss-1 and its receptor Kiss-1R in colorectal cancer.
 

Author(s): Ke Ji, Lin Ye, Fiona Ruge, Rachel Hargest, Malcolm D Mason, Wen G Jiang

Journal:

 

Kiss-1 and Kiss-1R have been suggested as a novel pair of metastasis suppressors for several human solid tumours, however, their role in colorectal cancer remains largely unknown. Therefore, the aim of this study was to investigate the role and signal transduction of Kiss-1 and Kiss-1R ...

Last Updated: 2 Oct 2014

Go To URL
Essential oil of Pinus koraiensis inhibits cell proliferation and migration via inhibition of p21-activated kinase 1 pathway in HCT116 colorectal cancer cells.
 

Author(s): Sun-Mi Cho, Eun-Ok Lee, Sung-Hoon Kim, Hyo-Jeong Lee

Journal:

 

The essential oil of Pinus koraiensis (EOPK) is biologically active compound obtained from the leaves of P. koraiensis. The goal of this study was to investigate the anti-cancer mechanism of EOPK in HCT116 colorectal cancer cells.

Last Updated: 18 Aug 2014

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Colorectal cancer 1" returned 1 free, full-text review articles on human participants. First 3 results:

Antineoplastic effects of 1,25(OH)2D3 and its analogs in breast, prostate and colorectal cancer.
 

Author(s): Carlien Leyssens, Lieve Verlinden, Annemieke Verstuyf

Journal:

 

The active form of vitamin D3, 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), is mostly known for its importance in the maintenance of calcium and phosphate homeostasis. However, next to its classical effects on bone, kidney and intestine, 1,25(OH)2D3 also exerts antineoplastic effects on ...

Last Updated: 25 Mar 2013

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer
 

Status: Recruiting

Condition Summary: Metastatic Pancreatic Cancer; Metastatic Colorectal Cancer

 

Last Updated: 23 Apr 2015

Go to URL
AMP-224, a PD-1 Inhibitor, in Combination With Stereotactic Body Radiation Therapy in People With Metastatic Colorectal Cancer
 

Status: Recruiting

Condition Summary: Colorectal Cancer; Colorectal Neoplasms; Colorectal Carcinoma

 

Last Updated: 25 Jul 2015

Go to URL

Last Updated: 1 Sep 2010

Go to URL